Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery.

by Tone F Bathen, Brigitte Geurts, Beathe Sitter, Hans E Fjøsne, Steinar Lundgren, Lutgarde M Buydens, Ingrid S Gribbestad, Geert Postma, Guro F Giskeødegård
Published 2013-01-01

Interactions between the tumor and the blood systemic response of breast cancer patients.

by Vanessa Dumeaux, Bjørn Fjukstad, Hans E Fjosne, Jan-Ole Frantzen, Marit Muri Holmen, Enno Rodegerdts, Ellen Schlichting, Anne-Lise Børresen-Dale, Lars Ailo Bongo, Eiliv Lund, Michael Hallett
Published 2017-09-01

Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel.

by Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Ostenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Gudbrand Skjønsberg, Turid Aas, Ellen Schlichting, Hans E Fjösne, Arne Nysted, Johan Richard Lillehaug, Per Eystein Lønning
Published 2011-04-01